1-Boc-吲哚啉 | 143262-10-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-Boc-吲哚啉
• 中文别名: 吲哚啉-1-羧酸叔丁酯；1-BOC-吲哚啉
• 英文名称: 1-(tert-butoxycarbonyl)indoline
• 英文别名: tert-butyl indoline-1-carboxylate；N-Boc-indoline；1,1-dimethylethyl 2,3-dihydro-1H-indole-1-carboxylate；tert-butyl 2,3-dihydroindole-1-carboxylate
• CAS: 143262-10-6
• 化学式: C₁₃H₁₇NO₂
• 分子量: 219.283
• InChiKey: GWAXLDLPPZPQLO-UHFFFAOYSA-N

物化性质

• 熔点：
  46-50 °C(lit.)
• 沸点：
  83-84 °C0.1 mm Hg(lit.)
• 密度：
  1.114±0.06 g/cm3(Predicted)
• 闪点：
  >230 °F
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2933990090
• WGK Germany：
  3
• 储存条件：
  保存方法：密封、阴凉、通风干燥处

反应信息

• 作为反应物：
  描述：

  1-Boc-吲哚啉 在 仲丁基锂 、 鹰爪豆碱 作用下， 以 乙醚 为溶剂， 反应 6.0h， 生成 methyl (R)-N-(tert-butoxycarbonyl)indoline-2-carboxylate
  参考文献：
  名称：

  Asymmetric Deprotonations:  Lithiation of N-(tert-Butoxycarbonyl)indoline with sec-Butyllithium/(−)-Sparteine

  摘要：

  The asymmetric lithiation of N-Boc indoline (1) with s-BuLi/(-)-sparteine and subsequent substitution provides the 2-substituted N-Boc indolines 3 and 5-11 with excellent enantiomeric ratios and in variable yields. The asymmetric lithiation-substitution sequence with N-Boc-7-chloroindoline (12) provides products 13-19 with good enantiomeric ratios. Mechanistic investigation establishes that the enantioselectivities arise from an initial asymmetric deprotonation to provide the enantioenriched and configurationally stable organolithium intermediates (S)-28 and (S)-29, which react stereoselectively with electrophiles.

  DOI：

  10.1021/jo9708856
• 作为产物：
  描述：

  1-Boc-吲哚 在 5%-palladium/activated carbon 、 氢气 作用下， 以 hexafluoropropan-2-ol 为溶剂， 50.0 ℃ 、700.01 kPa 条件下， 反应 8.0h， 以99%的产率得到1-Boc-吲哚啉
  参考文献：
  名称：

  六氟异丙醇：氢化吲哚衍生物的有力溶剂。选择性获得四氢吲哚或顺式融合的八氢吲哚†

  摘要：

  HFIP中的Pd / C用于在相对温和的条件下氢化吲哚衍生物，从而导致潜在的生物活性化合物的合成中间体。根据它们的取代，可以选择性地获得四氢吲哚或八氢吲哚。

  DOI：

  10.1039/c2ob25980j

文献信息

• Iridium(III)-Catalyzed Direct C-7 Amination of Indolines with Organic Azides
  作者：Kwangmin Shin、Sukbok Chang

  DOI：10.1021/jo5018475

  日期：2014.12.19

  Iridium-catalyzed regioselective C-7 amination of indolines has been achieved with organic azides as a facile nitrogen source. The developed procedure is convenient to perform even at room temperature and applicable to a wide range of substrates with high catalytic activity. Various types of organic azides (sulfonyl, aryl, and alkyl derivatives) were all successfully reacted under the present conditions

  用有机叠氮化物作为方便的氮源，已经完成了铱催化的吲哚的区域选择性C-7胺化反应。所开发的程序即使在室温下也很方便执行，并且适用于具有高催化活性的各种底物。在当前条件下，各种类型的有机叠氮化物（磺酰基，芳基和烷基衍生物）都作为可行的反应物成功地反应了。此外，轴承容易去除二氢吲哚基片Ñ保护基团如ñ -Boc或ñ -Cbz可容易地被采用，突出这种方法的合成的效用。
• Synthesis of Indolines via a Domino Cu-Catalyzed Amidation/Cyclization Reaction
  作者：Ana Minatti、Stephen L. Buchwald

  DOI：10.1021/ol8008792

  日期：2008.7.3

  A highly efficient one-pot procedure for the synthesis of indolines and their homologues based on a domino Cu-catalyzed amidation/nucleophilic substitution reaction has been developed. Substituted 2-iodophenethyl mesylates and related compounds afforded the corresponding products in excellent yields. No erosion of optical purity was observed when transforming enantiomerically pure mesylates under the

  已经开发了一种基于多米诺铜催化的酰胺化/亲核取代反应合成二氢吲哚及其同系物的高效一锅法。取代的 2-碘苯乙基甲磺酸酯和相关化合物以优异的产率提供了相应的产品。在反应条件下转化对映体纯的甲磺酸盐时，没有观察到光学纯度的降低。
• CHEMICAL COMPOUNDS
  申请人：Deng Jianghe

  公开号：US20090143372A1

  公开（公告）日：2009-06-04

  The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I: where R1, R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  这项发明涉及新型吲哚羧酰胺衍生物。具体而言，该发明涉及符合以下式I的化合物： 其中R1、R2、R3、U和V如下定义，并且其药学上可接受的盐。该发明的化合物是IKK2的抑制剂，可用于治疗与不当IKK2（也称为IKKβ）活性相关的疾病，如类风湿性关节炎、哮喘和慢性阻塞性肺病（COPD）。因此，该发明进一步涉及包含该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包含该发明化合物的药物组合物抑制IKK2活性和治疗相关疾病的方法。
• One-Pot Reductive Mono-N-alkylation of Aromatic Nitro Compounds Using Nitriles as Alkylating Reagents
  作者：Subhasish Neogi、Dinabandhu Naskar

  DOI：10.1080/00397911.2010.493627

  日期：2011.7.1

  Abstract A one-pot, simple, selective, and efficient protocol for the synthesis of aromatic secondary amines from various nitro arenes and nitriles in the presence of 10% Pd/C catalyst under H2 at atmospheric pressure and ambient temperature in tetrahydrofuran is illustrated. The scope and limitations of this method have been examined.

  摘要 说明了在常压和环境温度下在四氢呋喃中，在 H2 和 10% Pd/C 催化剂存在下，由各种硝基芳烃和腈合成芳香仲胺的一锅法、简单、选择性和高效的方案。已经检查了该方法的范围和局限性。
• Palladium-Catalyzed Reduction of <i>N</i>-(<i>tert</i>-Butoxycarbonyl)indoles by Polymethylhydrosiloxane
  作者：Srivari Chandrasekhar、Debjit Basu、Ch. Raji Reddy

  DOI：10.1055/s-2007-966029

  日期：——

  The palladium-catalyzed [10% Pd(OH)2/C] reduction of N-(tert-butoxycarbonyl)indoles to the corresponding N-(tert-butoxy­carbonyl)indolines is described. Polymethylhydrosiloxane was used as reducing agent and the reaction proceeded smoothly at room temperature in short reaction times giving the products in good yields.

  描述了钯催化（10% Pd(OH)2/C）还原N-叔丁氧羰基吲哚为相应N-叔丁氧羰基二氢吲哚的过程。使用聚甲基氢硅氧烷作为还原剂，在室温下短时间内反应顺利进行，产率良好。

表征谱图